Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders [Phase 4]
Phase 4 clinical trial update on multimodal neurobiological markers related to major depressive disorder and anxiety disorders.
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Trial of Asthma Self-Management Education in Patients With Depressive Symptoms [NA]
This clinical trial evaluated asthma self-management education in patients with depressive symptoms and has completed.
-
FDA approval · 2016-09-12FDA Approved: ARIPIPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved the original ANDA for a generic aripiprazole from Quallent Pharmaceuticals Health LLC. The approval covers a generic versio…
-
FDA label_change · 2016-09-09FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for desvenlafaxine, resulting in labeling changes.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program [NA]
A completed clinical trial evaluating Distance Savvy, a distance education program for dementia family caregivers (Tele-Savvy). Emory Univer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy [Phase 4]
Phase 4 study evaluating ketamine as the anaesthetic during electroconvulsive therapy for depression has completed. The trial was led by the…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients [NA]
This update reports the completion and posting of results for a pilot trial evaluating phototherapy as a treatment for acute depression in h…
-
FDA label_change · 2016-09-06FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) from Allergan, Inc.—updating the drug's labeling. This action…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial [Phase 4]
This completed Phase 4 pilot randomized trial evaluated minocycline as an adjunct therapy for depressive symptoms.
-
CLINICAL_TRIALS research · 2016-09-05Clinical Trial Update: Neural and Cognitive Mechanisms of Depression and Anxiety: a Multimodal MRI Study
An update on a multimodal MRI study investigating neural and cognitive mechanisms underlying depression.
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Music-with-Movement Intervention for People With Early Dementia and Their Families [NA]
A clinical trial evaluating a music-with-movement intervention for people with early dementia and their families has completed, addressing d…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Raloxifene and Rimostil for Perimenopause-Related Depression [Phase 4]
Phase 4 study by the National Institute of Mental Health evaluating raloxifene (Rimostil) for perimenopause-related depression and depressio…
-
CLINICAL_TRIALS withdrawal · 2016-09-02Clinical Trial Update: Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI) [Phase 3]
A Phase 3 clinical trial evaluating vortioxetine for major depressive disorder with co-morbid conditions following traumatic brain injury ha…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Depression Study In Elderly Patients [Phase 3]
A Phase 3 trial evaluating an antidepressant for major depressive disorder in elderly patients has completed.
-
CLINICAL_TRIALS research · 2016-08-31Clinical Trial Update: Predictors of Treatment Response in Late-onset Major Depressive Disorder
Clinical trial NCT02546024 from King's College London studying predictors of treatment response in late-onset major depressive disorder is c…
-
FDA approval · 2016-08-30FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) submitted by Bausch Health US LLC.
-
FDA label_change · 2016-08-30FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)
The FDA notes a supplemental application submission for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC, related to the product…
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: Effects of a Psychotherapy Intervention in Depressed Patients With Coronary Artery Disease [NA]
Clinical trial update on a psychotherapy intervention for patients with depression and coronary artery disease; the study status is complete…
-
FDA approval · 2016-08-26FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PRISTIQ Extended-Release (desvenlafaxine succinate) by Wyeth/Pfizer, resulting in labeling chang…
-
FDA approval · 2016-08-26FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals' Bupropion Hydrochloride (XL) under an Original Application (ANDA 206556) as a generic extended-release …
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G) [Phase 1]
Phase 1 clinical trial evaluating measurement and treatment of excessive sweating caused by antidepressants using glycopyrrolate (AIDES-G); …
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? [Phase 4]
A Phase 4 clinical trial testing vilazodone for antidepressant-associated sexual dysfunction has been terminated. The study included partici…
-
CLINICAL_TRIALS withdrawal · 2016-08-25Clinical Trial Update: Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease [EARLY_Phase 1]
The early-phase trial of vortioxetine in patients with major depressive disorder and coronary artery disease was withdrawn.
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder [Phase 4]
This document reports a Phase 4 clinical trial comparing vortioxetine to placebo in adults with major depressive disorder and comorbid socia…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress [Phase 3]
A Phase 3 safety trial evaluating flibanserin (Addyi) in depressed women taking an SSRI or SNRI with decreased sexual desire and distress wa…